Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yasuaki Ryushima"'
Autor:
Daisuke Ueki, Shinya Suzuki, Takahiro Ohta, Akira Shinohara, Yasukata Ohashi, Daisuke Konuma, Yasuaki Ryushima, Ryoko Udagawa, Hironori Motoshige, Masahiro Ieoka, Akihiro Taji, Yuuki Kogure, Mikako Hiraike, Miyuki Uoi, Kazuhiko Ino, Toshikatsu Kawasaki, Masakazu Yamaguchi
Publikováno v:
Pharmacy, Vol 12, Iss 1, p 1 (2023)
Although prescription review is an important role for pharmacists in anticancer drug therapy, there are no guidelines in Japan that specify what pharmacists should check for in chemotherapy regimens. This prospective multicenter survey aimed to inves
Externí odkaz:
https://doaj.org/article/affda06035f2417e91f2adfbc852a57e
Autor:
Masashi Ando, Yasuhiro Fujiwara, Akihiro Hirakawa, Kan Yonemori, Mari Saito, Chikako Shimizu, Mayu Yunokawa, Hiroshi Yamamoto, Kenji Tamura, Makoto Kodaira, Harukaze Yamamoto, Taizo Hirata, Yasuaki Ryushima
Publikováno v:
Pharmaceutical Medicine. 26:165-170
Pharmaceutical companies in Japan often provide a unique document called the Guidance for Proper Usage (GPU) to medical oncologists, in order to promote the proper use of an approved drug. The aim of the study was to examine the content of and curren
Autor:
Ryoko Udagawa, Satoshi Shiba, Jun Hashimoto, Tomoko Uehara, Miho Yano, Yasuaki Ryushima, Mihoko Asanabe, Kenji Tamura, Shunsuke Kondo
Publikováno v:
BMC Research Notes
Background An increasing number of cancer patients are receiving ambulatory chemotherapy to improve their quality of life and reduce medical expenses. During outpatient chemotherapy, adverse events (AEs) occurring at home must be carefully monitored.
Autor:
Yu-ichiro Azuma, Nobuaki Yokote, Hiroshi Yamamoto, Yoshinori Makino, Akihiro Hirakawa, Kimie Sai, Masahiro Tohkin, Norifumi Morikawa, Yoshiro Saito, Yasuhiro Fujiwara, Ryoko Udagawa, Kojiro Hata, Yasuaki Ryushima
Publikováno v:
Biologicalpharmaceutical bulletin. 35(5)
Capecitabine, an oral prodrug of 5-fluorouracil (5-FU), is a promising treatment for colorectal, breast and gastric cancers, but often causes hand-foot syndrome (HFS), the most common dose-limiting toxicity. The current study was conducted to investi
Autor:
Akiko, Kubo, Keiichi, Koido, Mari, Sawada, Yasuaki, Ryushima, Chikako, Shimizu, Tomoyasu, Kato, Masashi, Ando, Takayuki, Kinoshita, Koji, Murakoshi, Nobuaki, Yokote, Yasuhiro, Fujiwara, Hiroshi, Yamamoto
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(3)
Treatment-related infertility is an important issue facing breast cancer survivors of childbearing age. A previous study at the National Cancer Center Hospital between 2000 and 2004 analyzed 136 postoperative breast cancer patients under 40 years old
Autor:
Kaisuke Miyamoto, Chiyo K. Imamura, Akitaka Makiyama, Kazuhiko Sato, Kenji Tamura, Mitsuchika Hosoda, Yasutaka Chiba, Shinichiro Nakamura, Mihoko Doi, Shinya Tokunaga, Kazuhiro Yanagihara, Masato Takahashi, Yasuaki Ryushima, Toshimi Takano, Kenjiro Aogi, Koji Matsumoto, Kimiko Fujiwara, Toshiaki Saeki, Yasuo Hozumi
Publikováno v:
Journal of Clinical Oncology. 33:9598-9598
9598 Background: Superiority of palonosetron to granisetron is uncertain, for patients with breast cancer receiving both steroid and NK1 inhibitor against CINV caused by AC regimen. Methods: We con...
Autor:
Shunsuke Kondo, Satoshi Shiba, Ryoko Udagawa, Yasuaki Ryushima, Miho Yano, Tomoko Uehara, Mihoko Asanabe, Kenji Tamura, Jun Hashimoto
Publikováno v:
BMC Research Notes; Jul2015, Vol. 8 Issue 1, p1-7, 7p, 2 Diagrams, 3 Charts